v3.24.3
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Other Comprehensive Income / (Loss)
Retained Earnings
Beginning balance at Dec. 31, 2022 $ 23,988          
Increase (Decrease) in Temporary Equity [Roll Forward]            
Accretion adjustments of redeemable noncontrolling interest to redemption value 2,061          
Net income / (loss) attributable to common stockholders (209)          
Ending balance at Mar. 31, 2023 25,840          
Beginning balance (in shares) at Dec. 31, 2022   50,985,000        
Beginning balance at Dec. 31, 2022 598,859 $ 510 $ 497,199 $ (83,993) $ 0 $ 185,143
Beginning balance (in shares) at Dec. 31, 2022       1,533,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued in connection with equity-based plans (in shares)   270,000        
Common stock issued in connection with equity-based plans 1,311 $ 3 1,308      
Stock-based compensation expense 12,686   12,686      
Accretion adjustments of redeemable noncontrolling interest to redemption value (2,061)   (2,061)      
Net income / (loss) attributable to common stockholders 14,416         14,416
Other comprehensive (loss) income 170       170  
Ending balance (in shares) at Mar. 31, 2023   51,255,000        
Ending balance at Mar. 31, 2023 625,381 $ 513 509,132 $ (83,993) 170 199,559
Ending balance (in shares) at Mar. 31, 2023       1,533,000    
Beginning balance at Dec. 31, 2022 23,988          
Ending balance at Sep. 30, 2023 30,342          
Beginning balance (in shares) at Dec. 31, 2022   50,985,000        
Beginning balance at Dec. 31, 2022 598,859 $ 510 497,199 $ (83,993) 0 185,143
Beginning balance (in shares) at Dec. 31, 2022       1,533,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Purchases of treasury stock (in shares)       239,540    
Other comprehensive (loss) income 76          
Ending balance (in shares) at Sep. 30, 2023   51,688,000        
Ending balance at Sep. 30, 2023 667,698 $ 517 529,070 $ (96,847) 76 234,882
Ending balance (in shares) at Sep. 30, 2023       1,772,000    
Beginning balance at Mar. 31, 2023 25,840          
Increase (Decrease) in Temporary Equity [Roll Forward]            
Purchases of redeemable noncontrolling interest (1,238)          
Accretion adjustments of redeemable noncontrolling interest to redemption value 3,454          
Net income / (loss) attributable to common stockholders (188)          
Ending balance at Jun. 30, 2023 27,868          
Beginning balance (in shares) at Mar. 31, 2023   51,255,000        
Beginning balance at Mar. 31, 2023 625,381 $ 513 509,132 $ (83,993) 170 199,559
Beginning balance (in shares) at Mar. 31, 2023       1,533,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued in connection with equity-based plans (in shares)   270,000        
Common stock issued in connection with equity-based plans 202 $ 2 200      
Purchases of treasury stock (in shares)       134,000    
Purchase of treasury stock (6,726)     $ (6,726)    
Stock-based compensation expense 11,965   11,965      
Purchases of redeemable noncontrolling interest 406   406      
Accretion adjustments of redeemable noncontrolling interest to redemption value (3,454)   (3,454)      
Net income / (loss) attributable to common stockholders 15,799         15,799
Other comprehensive (loss) income 658       658  
Ending balance (in shares) at Jun. 30, 2023   51,525,000        
Ending balance at Jun. 30, 2023 644,231 $ 515 518,249 $ (90,719) 828 215,358
Ending balance (in shares) at Jun. 30, 2023       1,667,000    
Increase (Decrease) in Temporary Equity [Roll Forward]            
Accretion adjustments of redeemable noncontrolling interest to redemption value 2,647          
Net income / (loss) attributable to common stockholders (173)          
Ending balance at Sep. 30, 2023 30,342          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued in connection with equity-based plans (in shares)   163,000        
Common stock issued in connection with equity-based plans 1,616 $ 2 1,614      
Purchases of treasury stock (in shares)       105,285    
Purchase of treasury stock (6,128)     $ (6,128)    
Stock-based compensation expense 11,854   11,854      
Accretion adjustments of redeemable noncontrolling interest to redemption value (2,647)   (2,647)      
Net income / (loss) attributable to common stockholders 19,524       0 19,524
Other comprehensive (loss) income (752)       (752)  
Ending balance (in shares) at Sep. 30, 2023   51,688,000        
Ending balance at Sep. 30, 2023 667,698 $ 517 529,070 $ (96,847) 76 234,882
Ending balance (in shares) at Sep. 30, 2023       1,772,000    
Beginning balance at Dec. 31, 2023 36,308          
Increase (Decrease) in Temporary Equity [Roll Forward]            
Accretion adjustments of redeemable noncontrolling interest to redemption value 1,595          
Net income / (loss) attributable to common stockholders (191)          
Ending balance at Mar. 31, 2024 $ 37,712          
Beginning balance (in shares) at Dec. 31, 2023 51,888,838 51,889,000        
Beginning balance at Dec. 31, 2023 $ 688,546 $ 519 531,734 $ (111,291) 1,398 266,186
Beginning balance (in shares) at Dec. 31, 2023 2,020,663     2,021,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued in connection with equity-based plans (in shares)   224,000        
Common stock issued in connection with equity-based plans $ 6,356 $ 2 6,354      
Stock-based compensation expense 11,339   11,339      
Accretion adjustments of redeemable noncontrolling interest to redemption value (1,595)   (1,595)      
Net income / (loss) attributable to common stockholders 23,595         23,595
Other comprehensive (loss) income (147)       (147)  
Ending balance (in shares) at Mar. 31, 2024   52,113,000        
Ending balance at Mar. 31, 2024 728,094 $ 521 547,832 $ (111,291) 1,251 289,781
Ending balance (in shares) at Mar. 31, 2024       2,021,000    
Beginning balance at Dec. 31, 2023 36,308          
Ending balance at Sep. 30, 2024 $ 40,610          
Beginning balance (in shares) at Dec. 31, 2023 51,888,838 51,889,000        
Beginning balance at Dec. 31, 2023 $ 688,546 $ 519 531,734 $ (111,291) 1,398 266,186
Beginning balance (in shares) at Dec. 31, 2023 2,020,663     2,021,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Purchases of treasury stock (in shares)       1,117,068    
Purchase of treasury stock       $ (75,000)    
Other comprehensive (loss) income $ 375          
Ending balance (in shares) at Sep. 30, 2024 52,469,598 52,470,000        
Ending balance at Sep. 30, 2024 $ 690,301 $ 525 514,320 $ (186,291) 1,773 359,974
Ending balance (in shares) at Sep. 30, 2024 3,137,731     3,138,000    
Beginning balance at Mar. 31, 2024 $ 37,712          
Increase (Decrease) in Temporary Equity [Roll Forward]            
Accretion adjustments of redeemable noncontrolling interest to redemption value 1,212          
Net income / (loss) attributable to common stockholders (991)          
Ending balance at Jun. 30, 2024 37,933          
Beginning balance (in shares) at Mar. 31, 2024   52,113,000        
Beginning balance at Mar. 31, 2024 728,094 $ 521 547,832 $ (111,291) 1,251 289,781
Beginning balance (in shares) at Mar. 31, 2024       2,021,000    
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued in connection with equity-based plans (in shares)   209,000        
Common stock issued in connection with equity-based plans 378 $ 2 376      
Purchases of treasury stock (in shares)       1,117,000    
Purchase of treasury stock (75,559)   (559) $ (75,000)    
Tax withholding related to vesting of restricted stock units (3,401)   (3,401)      
Stock-based compensation expense 11,250   11,250      
Accretion adjustments of redeemable noncontrolling interest to redemption value (1,212)   (1,212)      
Purchases of capped calls related to convertible senior notes, net of tax (47,436)   (47,436)      
Net income / (loss) attributable to common stockholders 33,511         33,511
Other comprehensive (loss) income (156)       (156)  
Ending balance (in shares) at Jun. 30, 2024   52,322,000        
Ending balance at Jun. 30, 2024 645,469 $ 523 506,850 $ (186,291) 1,095 323,292
Ending balance (in shares) at Jun. 30, 2024       3,138,000    
Increase (Decrease) in Temporary Equity [Roll Forward]            
Accretion adjustments of redeemable noncontrolling interest to redemption value 2,903          
Net income / (loss) attributable to common stockholders (226)          
Ending balance at Sep. 30, 2024 40,610          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued in connection with equity-based plans (in shares)   148,000        
Common stock issued in connection with equity-based plans $ 1,106 $ 2 1,104      
Purchases of treasury stock (in shares) 0          
Changes in excise tax related to previous stock repurchases $ 51   51      
Stock-based compensation expense 9,218   9,218      
Accretion adjustments of redeemable noncontrolling interest to redemption value (2,903)   (2,903)      
Net income / (loss) attributable to common stockholders 36,682         36,682
Other comprehensive (loss) income $ 678       678  
Ending balance (in shares) at Sep. 30, 2024 52,469,598 52,470,000        
Ending balance at Sep. 30, 2024 $ 690,301 $ 525 $ 514,320 $ (186,291) $ 1,773 $ 359,974
Ending balance (in shares) at Sep. 30, 2024 3,137,731     3,138,000